Acquisition rumors?

Discussion in 'Exactech Orthopedics' started by anonymous, Sep 26, 2018 at 8:40 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    These rumors of us being bought have been going on for years now..... S&N was always the main one and that option is off the table. You would have to think they want to sell tho with TPG being the owner.... Who would you guys want it to be? If we were even to bet purchased.....
     

  2. anonymous

    anonymous Guest

    Why would ZB buy you? Same with J&J? Do you have a clue on who is running your company? You have a decent shoulder which I am sure will be improved upon to actually compete at a higher level with ZB because you now have Biomet engineers as well as surgeon consultants. Your knee needs major improvement and your hips are average. Navigation for shoulders is a joke. ZB and J&J? Who knows if J&J will keep DePuy? You have sharp leadership that knows how to fix the areas you have neglected. Question is? How much money the investment group wants to put in? Maybe Arthrex?
     
  3. anonymous

    anonymous Guest

    Hearing there are serious lookers kicking the tires around Naples. Only a matter of time.
     
  4. anonymous

    anonymous Guest

    We were bought by a venture capital group to specifically be sold for more than they paid. They buy companies for less than they sell them for. It’s business for them and they’ll be on to the next company.
     
  5. anonymous

    anonymous Guest

    Very well said but I don’t think the idea is whether we will be sold but who is going to buy us?
     
  6. anonymous

    anonymous Guest

    Pending knee litigation is slowing the process down.
     
  7. anonymous

    anonymous Guest

    Interesting thread, we were bought to later be sold. We are an asset for the Venture Capital group. We will be sold!
     
  8. anonymous

    anonymous Guest

    The big 3 control the market period! Smith and Nephew on down the line are always on the block and can be acquired at anytime. None of us will organically grow enough to be a significant player. Mergers and acquisitions is the future.
     
  9. anonymous

    anonymous Guest

    M&A is definitely the future and it’s not all bad. We want to get bigger, we want scale along with other smaller companies so the M&A model works. Medtronic, Nuvasive?
     
  10. anonymous

    anonymous Guest

    Medtronic
     
  11. anonymous

    anonymous Guest

    End of the year, if a company is looking to buy now is the time. A big spine player has to step up and want in the total game and us and S&N are the last reasonable targets.
     
  12. anonymous

    anonymous Guest

    Uh, unless you have an equity stake, I’d be careful what you wish for.
     
  13. anonymous

    anonymous Guest

    Stuart is bring ZB to the table, interesting potential buyer. ZB just writes a check
     
  14. anonymous

    anonymous Guest

    Zero chance of this. What do we have that ZB needs? It would be another Biomet deal, which Z has has regretted from day one. ZB got sports and upgraded their upper extremities portfolio, and that’s it...rationalizing nearly everything else. ZB Connecticut flunkies desperately looking for their own payout via a ZB sale (world’s worst kept secret).
     
  15. anonymous

    anonymous Guest

    Totally agree with the ZB comments above. I’m hearing Arthrex has been in looking around. Nothing but rumors at this point but you never know.
     
  16. anonymous

    anonymous Guest

    I’ve heard about Arthrex as well. Makes total sense and I like the culture there. Great company that wants to be a little bigger, why not?
     
  17. anonymous

    anonymous Guest

    Both companies located near each other makes sense to me. I’d welcome their deep pockets and leadership
     
  18. anonymous

    anonymous Guest

    I hope that when we are finally bought that they keep us, not just are products. All in all we are a good company.
     
  19. anonymous

    anonymous Guest

    We’ll be invaluable for the Arthrex people or whoever buys us. We know the products and have the relationships. Management will be gone but the field reps will be solid.